Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety

Expert Opinion on Drug Metabolism & Toxicology
Janet SultanaGianluca Trifirò

Abstract

Antidepressants (ADs) are widely used among elderly persons, making AD-related safety an important issue. This review highlights safety considerations related to AD use including risks associated with inappropriate and off-label use. The age-related pharmacokinetic and pharmacodynamic changes underlying safety concerns connected to ADs are outlined. Drug-drug interactions as a cause of AD-related adverse drug reactions (ADRs) are also discussed. We reviewed scientific evidence concerning three important safety outcomes related to ADs in elderly persons: cardiac arrhythmias, hyponatraemia and falls/fractures. Several AD-related ADRs in elderly people are likely to be preventable. Current evidence suggests that selective serotonin re-uptake inhibitors (SSRIs) are best avoided particularly in persons with kidney disease due to the risk of hyponatraemia. The use of tricyclic antidepressants (TCAs) should be limited in the elderly due to anticholinergic adverse effects. TCAs should also be avoided in elderly persons at high risk of cardiovascular events due to a risk of cardiac arrhythmia. Emerging evidence suggests that SSRIs also have arrhythmogenic potential. Both TCAs and SSRIs should be used cautiously in elderly persons at ris...Continue Reading

References

May 8, 1995·Archives of Internal Medicine·E L SieglerB L Strom
Feb 12, 1994·Lancet·W M Drake, G D Gordon
Apr 10, 1993·Lancet·T WalleyD Maxwell
Jun 1, 1996·Journal of Clinical Psychopharmacology·R L Rudolph, A T Derivan
May 30, 1998·Archives of Internal Medicine·A LeibovitzB Habot
Jul 23, 1998·Clinical Pharmacokinetics·A HämmerleinD T Lowenthal
Sep 24, 1998·The New England Journal of Medicine·P B ThapaW A Ray
Mar 6, 2002·Current Drug Metabolism·Alex Hemeryck, Frans M Belpaire
Apr 23, 2002·British Journal of Clinical Pharmacology·Kris L L MovigAntoine C G Egberts
May 16, 2002·European Journal of Clinical Pharmacology·K L L MovigA C G Egberts
Jun 1, 2002·Drugs & Aging·Edoardo Spina, Maria Gabriella Scordo
Oct 24, 2002·Gerontology·Stuart A Montgomery
Jan 25, 2003·Journal of Clinical Psychopharmacology·Harry J WitchelDavid J Nutt
May 20, 2003·Journal of the American Geriatrics Society·Rajender R AparasuHeather Brandt
Jul 2, 2003·American Journal of Epidemiology·Richard HubbardAnne Tattersfield
Mar 6, 2004·Clinical Pharmacology and Therapeutics·Wayne A RayKatherine T Murray
Aug 24, 2004·Current Pharmaceutical Design·Pal Pacher, Valeria Kecskemeti
Dec 21, 2004·British Journal of Clinical Pharmacology·David N JuurlinkAndreas Laupacis
Mar 24, 2005·The New England Journal of Medicine·Edward W Boyer, Michael Shannon
Apr 12, 2005·Journal of the American Academy of Nurse Practitioners·Maryann M Fulton, Elizabeth Riley Allen
Jul 20, 2005·Journal of Clinical Psychopharmacology·Steven P Roose, Alan F Schatzberg
Sep 21, 2005·Journal of Clinical Pharmacology·Francis E Lotrich, Bruce G Pollock
Oct 28, 2005·The New England Journal of Medicine·J John Mann
Feb 8, 2006·Postgraduate Medical Journal·R Peters
Mar 7, 2006·Lancet·Norio Yasui-Furukori, Sunao Kaneko
May 1, 2007·Aging Cell·Dara L DicksteinPatrick R Hof
May 3, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joachim WernickeFujun Wang
Oct 9, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Sirpa HartikainenKirsti Louhivuori
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Mark W Bowie, Patricia W Slattum
Jan 1, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Michael BauerAndre Tylee
Jan 30, 2008·Archives of Internal Medicine·Tom SchalekampAnthonius de Boer
Feb 25, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M W M van den BrandF de Vries
Mar 21, 2009·Pharmacoepidemiology and Drug Safety·Susanna M WallerstedtLars Ny
Nov 18, 2009·British Journal of Clinical Pharmacology·Kate JollyMichael J S Langman
Jul 12, 2011·Therapeutic Drug Monitoring·Kelly A CochranJeffrey R Bishop
Jul 29, 2011·Pharmacoepidemiology and Drug Safety·Charles E LeonardSean Hennessy
Aug 4, 2011·BMJ : British Medical Journal·Carol CouplandJulia Hippisley-Cox
Aug 10, 2011·Journal of the American Geriatrics Society·Joseph T HanlonMaurice W Dysken
Sep 10, 2011·Drug, Healthcare and Patient Safety·L Leanne LaiYen Chi Lai
Oct 1, 2011·BMJ : British Medical Journal·Joanne RoddaJanet Carter
Dec 17, 2011·CNS Drugs·Edoardo SpinaFilippo Caraci

❮ Previous
Next ❯

Citations

Feb 18, 2016·Expert Review of Neurotherapeutics·Radoslaw Magierski, Tomasz Sobow
Nov 20, 2016·Fundamental & Clinical Pharmacology·David BraunsteinJoëlle Micallef
Mar 3, 2018·International Journal of Molecular Sciences·Nan MiaoTao Sun
Jan 31, 2018·International Psychogeriatrics·Svetla GadzhanovaLisa G Pont
Jan 18, 2020·Aging & Mental Health·Mercy Ngosa MumbaRebecca S Allen
Dec 13, 2019·Stroke; a Journal of Cerebral Circulation·Phillip J TullyChristophe Tzourio
Feb 28, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N N Petrova, A V Markin
Mar 7, 2020·Journal of Clinical Psychopharmacology·Annalisa BiffiUNKNOWN Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)
Aug 31, 2016·The Mental Health Clinician·Bridget BradleyEmily Gray
May 17, 2017·Journal of Alzheimer's Disease : JAD·Vasiliki OrgetaRobert Howard
Mar 13, 2020·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Takayuki SugaAkira Toyofuku
Oct 20, 2017·European Journal of Clinical Pharmacology·A BiffiUNKNOWN Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)
Aug 2, 2020·Journal of the American Medical Directors Association·Anne-Bahia AbdeljalilMaria Soto
Mar 16, 2021·European Geriatric Medicine·E P van PoelgeestN van der Velde
Oct 21, 2020·Journal of the American Medical Directors Association·Enrico CallegariSverre Bergh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.